---
id: FC-007
type: Flashcard
created: 2025-08-08 09:58:30.214424
tags:
- Flashcard
- question
- endocrine
topic: endocrine
answer: B
related_articles:
- title: In Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major
    Adverse Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.
  path: 2025/2025-03-in-older-adults-with-type-2-diabetes-glp-1-receptor-agonists.md
  similarity: 0.778
  link: '[[2025/2025-03-in-older-adults-with-type-2-diabetes-glp-1-receptor-agonists|In
    Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major Adverse
    Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.]]'
- title: DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT-2 Inhibitors for People
    With Cardiovascular Disease.
  path: 2022/2022-07-dpp-4-inhibitors-glp-1-receptor-agonists-and-sglt-2-inhibito.md
  similarity: 0.75
  link: '[[2022/2022-07-dpp-4-inhibitors-glp-1-receptor-agonists-and-sglt-2-inhibito|DPP-4
    Inhibitors, GLP-1 Receptor Agonists, and SGLT-2 Inhibitors for People With Cardiovascular
    Disease.]]'
- title: SGLT-2 Inhibitors Reduce Heart Failure-Related Hospitalization in Patients
    Without Diabetes.
  path: 2022/2022-10-sglt-2-inhibitors-reduce-heart-failure-related-hospitalizati.md
  similarity: 0.6
  link: '[[2022/2022-10-sglt-2-inhibitors-reduce-heart-failure-related-hospitalizati|SGLT-2
    Inhibitors Reduce Heart Failure-Related Hospitalization in Patients Without Diabetes.]]'
- title: Liraglutide Is Probably the Best Second Drug to Prevent Cardiovascular Events
    in Patients With Type 2 Diabetes Mellitus Who Take Metformin.
  path: 2023/2023-04-liraglutide-is-probably-the-best-second-drug-to-prevent-card.md
  similarity: 0.6
  link: '[[2023/2023-04-liraglutide-is-probably-the-best-second-drug-to-prevent-card|Liraglutide
    Is Probably the Best Second Drug to Prevent Cardiovascular Events in Patients
    With Type 2 Diabetes Mellitus Who Take Metformin.]]'
- title: SGLT-2 Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest,
    Even in Patients With Established Heart Disease.
  path: 2025/2025-01-sglt-2-inhibitors-reduce-cardiovascular-mortality-but-benefi.md
  similarity: 0.556
  link: '[[2025/2025-01-sglt-2-inhibitors-reduce-cardiovascular-mortality-but-benefi|SGLT-2
    Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest, Even in Patients
    With Established Heart Disease.]]'
topics:
- Cardiology
- Emergency Medicine
- Endocrinology
- Neurology
- Pharmacology
- Psychiatry
---

# Flashcard FC-007

## Question

which one of the followingstatementsaboutprediabetesordiabetesmellitusis correct? Inpatientswithprediabetes,anintensivelifestyleinterventionhasbeenshowntoimprovelong-term cardiovascularrisk. Mostolderadultswithprediabetesdonotdevelopdiabetes. Drug-inducedhypoglycemiaisuncommoninfrailolderadults. Combinationtherapyfordiabeticperipheralneuropathydoesnotimprovepainmoreeffectivelythan monotherapy @ Back

## Answer

**B**

## Explanation

Inpatientswithprediabetes,neitheranintensivelifestyleinterventionnormetforminhadanyimpacton thelong-termriskofcardiovascularoutcomes. Inacohortstudyofadultsolderthan60 years,thosewith prediabetesweremorelikelytobecomenormoglycemicthantodevelopdiabetesordie. Morethan75 ofolderadultswithtype2 diabeteswhowerelivinginnursinghomeshadatleastonehypoglycemic eventduringtwoweeksofmonitoring,andnearly50 experiencedseverehypoglycemia. Therewas greaterimprovementinpainfuldiabeticperipheralneuropathywithsubsequentcombinationtherapy regardlessofinitialchoiceofmedication e

## References

- AAFPQuestion Bank-Pythonsimplecapture.
- whowerelivinginnursinghomeshadatleastonehypoglycemic

